Pharma & Healthcare
Global Urea Cycle Disorder Agent Market Research Report 2026
- Feb 24, 26
- ID: 718230
- Pages: 104
- Figures: 106
- Views: 3
This report delivers a comprehensive overview of the global Urea Cycle Disorder Agent market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Urea Cycle Disorder Agent. The Urea Cycle Disorder Agent market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Urea Cycle Disorder Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Urea Cycle Disorder Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Horizon Pharma
Lee's Pharmaceutical
Medunik
Sigmapharm Laboratories
Amgen
Acer Therapeutics
Immedica
Segment by Type
Glycerol Phenylbutyrate
Sodium Phenylbutyrate
Segment by Application
Hospital
Pharmacy
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Urea Cycle Disorder Agent companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Urea Cycle Disorder Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Urea Cycle Disorder Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Horizon Pharma
Lee's Pharmaceutical
Medunik
Sigmapharm Laboratories
Amgen
Acer Therapeutics
Immedica
Segment by Type
Glycerol Phenylbutyrate
Sodium Phenylbutyrate
Segment by Application
Hospital
Pharmacy
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Urea Cycle Disorder Agent companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorder Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.3 Market by Application
1.3.1 Global Urea Cycle Disorder Agent Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorder Agent Market Perspective (2021–2032)
2.2 Global Urea Cycle Disorder Agent Growth Trends by Region
2.2.1 Global Urea Cycle Disorder Agent Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Urea Cycle Disorder Agent Historic Market Size by Region (2021–2026)
2.2.3 Urea Cycle Disorder Agent Forecasted Market Size by Region (2027–2032)
2.3 Urea Cycle Disorder Agent Market Dynamics
2.3.1 Urea Cycle Disorder Agent Industry Trends
2.3.2 Urea Cycle Disorder Agent Market Drivers
2.3.3 Urea Cycle Disorder Agent Market Challenges
2.3.4 Urea Cycle Disorder Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorder Agent Players by Revenue
3.1.1 Global Top Urea Cycle Disorder Agent Players by Revenue (2021–2026)
3.1.2 Global Urea Cycle Disorder Agent Revenue Market Share by Players (2021–2026)
3.2 Global Top Urea Cycle Disorder Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorder Agent Revenue
3.4 Global Urea Cycle Disorder Agent Market Concentration Ratio
3.4.1 Global Urea Cycle Disorder Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorder Agent Revenue in 2025
3.5 Global Key Players of Urea Cycle Disorder Agent Head Offices and Areas Served
3.6 Global Key Players of Urea Cycle Disorder Agent, Products and Applications
3.7 Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Urea Cycle Disorder Agent Breakdown Data by Type
4.1 Global Urea Cycle Disorder Agent Historic Market Size by Type (2021–2026)
4.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Type (2027–2032)
5 Urea Cycle Disorder Agent Breakdown Data by Application
5.1 Global Urea Cycle Disorder Agent Historic Market Size by Application (2021–2026)
5.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Urea Cycle Disorder Agent Market Size (2021–2032)
6.2 North America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
6.4 North America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorder Agent Market Size (2021–2032)
7.2 Europe Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Urea Cycle Disorder Agent Market Size by Country (2021–2026)
7.4 Europe Urea Cycle Disorder Agent Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorder Agent Market Size (2021–2032)
8.2 Asia-Pacific Urea Cycle Disorder Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2021–2026)
8.4 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Urea Cycle Disorder Agent Market Size (2021–2032)
9.2 Latin America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
9.4 Latin America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorder Agent Market Size (2021–2032)
10.2 Middle East & Africa Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2021–2026)
10.4 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Pharma
11.1.1 Horizon Pharma Company Details
11.1.2 Horizon Pharma Business Overview
11.1.3 Horizon Pharma Urea Cycle Disorder Agent Introduction
11.1.4 Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.1.5 Horizon Pharma Recent Development
11.2 Lee's Pharmaceutical
11.2.1 Lee's Pharmaceutical Company Details
11.2.2 Lee's Pharmaceutical Business Overview
11.2.3 Lee's Pharmaceutical Urea Cycle Disorder Agent Introduction
11.2.4 Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.2.5 Lee's Pharmaceutical Recent Development
11.3 Medunik
11.3.1 Medunik Company Details
11.3.2 Medunik Business Overview
11.3.3 Medunik Urea Cycle Disorder Agent Introduction
11.3.4 Medunik Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.3.5 Medunik Recent Development
11.4 Sigmapharm Laboratories
11.4.1 Sigmapharm Laboratories Company Details
11.4.2 Sigmapharm Laboratories Business Overview
11.4.3 Sigmapharm Laboratories Urea Cycle Disorder Agent Introduction
11.4.4 Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.4.5 Sigmapharm Laboratories Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Urea Cycle Disorder Agent Introduction
11.5.4 Amgen Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.5.5 Amgen Recent Development
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Details
11.6.2 Acer Therapeutics Business Overview
11.6.3 Acer Therapeutics Urea Cycle Disorder Agent Introduction
11.6.4 Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.6.5 Acer Therapeutics Recent Development
11.7 Immedica
11.7.1 Immedica Company Details
11.7.2 Immedica Business Overview
11.7.3 Immedica Urea Cycle Disorder Agent Introduction
11.7.4 Immedica Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.7.5 Immedica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urea Cycle Disorder Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Glycerol Phenylbutyrate
1.2.3 Sodium Phenylbutyrate
1.3 Market by Application
1.3.1 Global Urea Cycle Disorder Agent Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urea Cycle Disorder Agent Market Perspective (2021–2032)
2.2 Global Urea Cycle Disorder Agent Growth Trends by Region
2.2.1 Global Urea Cycle Disorder Agent Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Urea Cycle Disorder Agent Historic Market Size by Region (2021–2026)
2.2.3 Urea Cycle Disorder Agent Forecasted Market Size by Region (2027–2032)
2.3 Urea Cycle Disorder Agent Market Dynamics
2.3.1 Urea Cycle Disorder Agent Industry Trends
2.3.2 Urea Cycle Disorder Agent Market Drivers
2.3.3 Urea Cycle Disorder Agent Market Challenges
2.3.4 Urea Cycle Disorder Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urea Cycle Disorder Agent Players by Revenue
3.1.1 Global Top Urea Cycle Disorder Agent Players by Revenue (2021–2026)
3.1.2 Global Urea Cycle Disorder Agent Revenue Market Share by Players (2021–2026)
3.2 Global Top Urea Cycle Disorder Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Urea Cycle Disorder Agent Revenue
3.4 Global Urea Cycle Disorder Agent Market Concentration Ratio
3.4.1 Global Urea Cycle Disorder Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urea Cycle Disorder Agent Revenue in 2025
3.5 Global Key Players of Urea Cycle Disorder Agent Head Offices and Areas Served
3.6 Global Key Players of Urea Cycle Disorder Agent, Products and Applications
3.7 Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Urea Cycle Disorder Agent Breakdown Data by Type
4.1 Global Urea Cycle Disorder Agent Historic Market Size by Type (2021–2026)
4.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Type (2027–2032)
5 Urea Cycle Disorder Agent Breakdown Data by Application
5.1 Global Urea Cycle Disorder Agent Historic Market Size by Application (2021–2026)
5.2 Global Urea Cycle Disorder Agent Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Urea Cycle Disorder Agent Market Size (2021–2032)
6.2 North America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
6.4 North America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urea Cycle Disorder Agent Market Size (2021–2032)
7.2 Europe Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Urea Cycle Disorder Agent Market Size by Country (2021–2026)
7.4 Europe Urea Cycle Disorder Agent Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Urea Cycle Disorder Agent Market Size (2021–2032)
8.2 Asia-Pacific Urea Cycle Disorder Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2021–2026)
8.4 Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Urea Cycle Disorder Agent Market Size (2021–2032)
9.2 Latin America Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Urea Cycle Disorder Agent Market Size by Country (2021–2026)
9.4 Latin America Urea Cycle Disorder Agent Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urea Cycle Disorder Agent Market Size (2021–2032)
10.2 Middle East & Africa Urea Cycle Disorder Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2021–2026)
10.4 Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Horizon Pharma
11.1.1 Horizon Pharma Company Details
11.1.2 Horizon Pharma Business Overview
11.1.3 Horizon Pharma Urea Cycle Disorder Agent Introduction
11.1.4 Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.1.5 Horizon Pharma Recent Development
11.2 Lee's Pharmaceutical
11.2.1 Lee's Pharmaceutical Company Details
11.2.2 Lee's Pharmaceutical Business Overview
11.2.3 Lee's Pharmaceutical Urea Cycle Disorder Agent Introduction
11.2.4 Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.2.5 Lee's Pharmaceutical Recent Development
11.3 Medunik
11.3.1 Medunik Company Details
11.3.2 Medunik Business Overview
11.3.3 Medunik Urea Cycle Disorder Agent Introduction
11.3.4 Medunik Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.3.5 Medunik Recent Development
11.4 Sigmapharm Laboratories
11.4.1 Sigmapharm Laboratories Company Details
11.4.2 Sigmapharm Laboratories Business Overview
11.4.3 Sigmapharm Laboratories Urea Cycle Disorder Agent Introduction
11.4.4 Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.4.5 Sigmapharm Laboratories Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview
11.5.3 Amgen Urea Cycle Disorder Agent Introduction
11.5.4 Amgen Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.5.5 Amgen Recent Development
11.6 Acer Therapeutics
11.6.1 Acer Therapeutics Company Details
11.6.2 Acer Therapeutics Business Overview
11.6.3 Acer Therapeutics Urea Cycle Disorder Agent Introduction
11.6.4 Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.6.5 Acer Therapeutics Recent Development
11.7 Immedica
11.7.1 Immedica Company Details
11.7.2 Immedica Business Overview
11.7.3 Immedica Urea Cycle Disorder Agent Introduction
11.7.4 Immedica Revenue in Urea Cycle Disorder Agent Business (2021–2026)
11.7.5 Immedica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Urea Cycle Disorder Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Glycerol Phenylbutyrate
Table 3. Key Players of Sodium Phenylbutyrate
Table 4. Global Urea Cycle Disorder Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
Table 7. Global Urea Cycle Disorder Agent Market Share by Region (2021–2026)
Table 8. Global Urea Cycle Disorder Agent Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Urea Cycle Disorder Agent Market Share by Region (2027–2032)
Table 10. Urea Cycle Disorder Agent Market Trends
Table 11. Urea Cycle Disorder Agent Market Drivers
Table 12. Urea Cycle Disorder Agent Market Challenges
Table 13. Urea Cycle Disorder Agent Market Restraints
Table 14. Global Urea Cycle Disorder Agent Revenue by Players (US$ Million), 2021–2026
Table 15. Global Urea Cycle Disorder Agent Market Share by Players (2021–2026)
Table 16. Global Top Urea Cycle Disorder Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Urea Cycle Disorder Agent Revenue, 2025
Table 17. Ranking of Global Top Urea Cycle Disorder Agent Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Urea Cycle Disorder Agent Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Urea Cycle Disorder Agent, Headquarters and Area Served
Table 20. Global Key Players of Urea Cycle Disorder Agent, Products and Applications
Table 21. Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Urea Cycle Disorder Agent Market Size by Type (US$ Million), 2021–2026
Table 24. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2021–2026)
Table 25. Global Urea Cycle Disorder Agent Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2027–2032)
Table 27. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2026
Table 28. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2021–2026)
Table 29. Global Urea Cycle Disorder Agent Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2027–2032)
Table 31. North America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 33. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Urea Cycle Disorder Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 46. Horizon Pharma Company Details
Table 47. Horizon Pharma Business Overview
Table 48. Horizon Pharma Urea Cycle Disorder Agent Product
Table 49. Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 50. Horizon Pharma Recent Development
Table 51. Lee's Pharmaceutical Company Details
Table 52. Lee's Pharmaceutical Business Overview
Table 53. Lee's Pharmaceutical Urea Cycle Disorder Agent Product
Table 54. Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 55. Lee's Pharmaceutical Recent Development
Table 56. Medunik Company Details
Table 57. Medunik Business Overview
Table 58. Medunik Urea Cycle Disorder Agent Product
Table 59. Medunik Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 60. Medunik Recent Development
Table 61. Sigmapharm Laboratories Company Details
Table 62. Sigmapharm Laboratories Business Overview
Table 63. Sigmapharm Laboratories Urea Cycle Disorder Agent Product
Table 64. Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 65. Sigmapharm Laboratories Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Urea Cycle Disorder Agent Product
Table 69. Amgen Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 70. Amgen Recent Development
Table 71. Acer Therapeutics Company Details
Table 72. Acer Therapeutics Business Overview
Table 73. Acer Therapeutics Urea Cycle Disorder Agent Product
Table 74. Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 75. Acer Therapeutics Recent Development
Table 76. Immedica Company Details
Table 77. Immedica Business Overview
Table 78. Immedica Urea Cycle Disorder Agent Product
Table 79. Immedica Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 80. Immedica Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Urea Cycle Disorder Agent Picture
Figure 2. Global Urea Cycle Disorder Agent Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Urea Cycle Disorder Agent Market Share by Type: 2025 vs 2032
Figure 4. Glycerol Phenylbutyrate Features
Figure 5. Sodium Phenylbutyrate Features
Figure 6. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Urea Cycle Disorder Agent Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Urea Cycle Disorder Agent Report Years Considered
Figure 11. Global Urea Cycle Disorder Agent Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Urea Cycle Disorder Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Urea Cycle Disorder Agent Market Share by Region: 2025 vs 2032
Figure 14. Global Urea Cycle Disorder Agent Market Share by Players in 2025
Figure 15. Global Urea Cycle Disorder Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Urea Cycle Disorder Agent Revenue in 2025
Figure 17. North America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 19. United States Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 23. Germany Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Urea Cycle Disorder Agent Market Share by Region (2021–2032)
Figure 31. China Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 39. Mexico Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 43. Israel Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Horizon Pharma Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 47. Lee's Pharmaceutical Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 48. Medunik Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 49. Sigmapharm Laboratories Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 50. Amgen Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 51. Acer Therapeutics Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 52. Immedica Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global Urea Cycle Disorder Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Glycerol Phenylbutyrate
Table 3. Key Players of Sodium Phenylbutyrate
Table 4. Global Urea Cycle Disorder Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
Table 7. Global Urea Cycle Disorder Agent Market Share by Region (2021–2026)
Table 8. Global Urea Cycle Disorder Agent Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Urea Cycle Disorder Agent Market Share by Region (2027–2032)
Table 10. Urea Cycle Disorder Agent Market Trends
Table 11. Urea Cycle Disorder Agent Market Drivers
Table 12. Urea Cycle Disorder Agent Market Challenges
Table 13. Urea Cycle Disorder Agent Market Restraints
Table 14. Global Urea Cycle Disorder Agent Revenue by Players (US$ Million), 2021–2026
Table 15. Global Urea Cycle Disorder Agent Market Share by Players (2021–2026)
Table 16. Global Top Urea Cycle Disorder Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Urea Cycle Disorder Agent Revenue, 2025
Table 17. Ranking of Global Top Urea Cycle Disorder Agent Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Urea Cycle Disorder Agent Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Urea Cycle Disorder Agent, Headquarters and Area Served
Table 20. Global Key Players of Urea Cycle Disorder Agent, Products and Applications
Table 21. Global Key Players of Urea Cycle Disorder Agent, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Urea Cycle Disorder Agent Market Size by Type (US$ Million), 2021–2026
Table 24. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2021–2026)
Table 25. Global Urea Cycle Disorder Agent Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Urea Cycle Disorder Agent Revenue Market Share by Type (2027–2032)
Table 27. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2026
Table 28. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2021–2026)
Table 29. Global Urea Cycle Disorder Agent Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Urea Cycle Disorder Agent Revenue Market Share by Application (2027–2032)
Table 31. North America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 33. North America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Urea Cycle Disorder Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Urea Cycle Disorder Agent Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Urea Cycle Disorder Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Urea Cycle Disorder Agent Market Size by Country (US$ Million), 2027–2032
Table 46. Horizon Pharma Company Details
Table 47. Horizon Pharma Business Overview
Table 48. Horizon Pharma Urea Cycle Disorder Agent Product
Table 49. Horizon Pharma Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 50. Horizon Pharma Recent Development
Table 51. Lee's Pharmaceutical Company Details
Table 52. Lee's Pharmaceutical Business Overview
Table 53. Lee's Pharmaceutical Urea Cycle Disorder Agent Product
Table 54. Lee's Pharmaceutical Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 55. Lee's Pharmaceutical Recent Development
Table 56. Medunik Company Details
Table 57. Medunik Business Overview
Table 58. Medunik Urea Cycle Disorder Agent Product
Table 59. Medunik Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 60. Medunik Recent Development
Table 61. Sigmapharm Laboratories Company Details
Table 62. Sigmapharm Laboratories Business Overview
Table 63. Sigmapharm Laboratories Urea Cycle Disorder Agent Product
Table 64. Sigmapharm Laboratories Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 65. Sigmapharm Laboratories Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Urea Cycle Disorder Agent Product
Table 69. Amgen Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 70. Amgen Recent Development
Table 71. Acer Therapeutics Company Details
Table 72. Acer Therapeutics Business Overview
Table 73. Acer Therapeutics Urea Cycle Disorder Agent Product
Table 74. Acer Therapeutics Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 75. Acer Therapeutics Recent Development
Table 76. Immedica Company Details
Table 77. Immedica Business Overview
Table 78. Immedica Urea Cycle Disorder Agent Product
Table 79. Immedica Revenue in Urea Cycle Disorder Agent Business (US$ Million), 2021–2026
Table 80. Immedica Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report
List of Figures
Figure 1. Urea Cycle Disorder Agent Picture
Figure 2. Global Urea Cycle Disorder Agent Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Urea Cycle Disorder Agent Market Share by Type: 2025 vs 2032
Figure 4. Glycerol Phenylbutyrate Features
Figure 5. Sodium Phenylbutyrate Features
Figure 6. Global Urea Cycle Disorder Agent Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Urea Cycle Disorder Agent Market Share by Application: 2025 vs 2032
Figure 8. Hospital Case Studies
Figure 9. Pharmacy Case Studies
Figure 10. Urea Cycle Disorder Agent Report Years Considered
Figure 11. Global Urea Cycle Disorder Agent Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Urea Cycle Disorder Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Urea Cycle Disorder Agent Market Share by Region: 2025 vs 2032
Figure 14. Global Urea Cycle Disorder Agent Market Share by Players in 2025
Figure 15. Global Urea Cycle Disorder Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Urea Cycle Disorder Agent Revenue in 2025
Figure 17. North America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 19. United States Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 23. Germany Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Urea Cycle Disorder Agent Market Share by Region (2021–2032)
Figure 31. China Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 39. Mexico Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Urea Cycle Disorder Agent Market Share by Country (2021–2032)
Figure 43. Israel Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Urea Cycle Disorder Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Horizon Pharma Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 47. Lee's Pharmaceutical Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 48. Medunik Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 49. Sigmapharm Laboratories Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 50. Amgen Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 51. Acer Therapeutics Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 52. Immedica Revenue Growth Rate in Urea Cycle Disorder Agent Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232